FDA approves Fitbit emergency ventilator 

The FDA granted Fitbit emergency use authorization for its new emergency ventilator, which it developed with help from Boston-based Massachusetts General Brigham and Portland-based Oregon Health & Science University. 

The Fitbit Flow ventilator is approved for use to treat COVID-19 patients specifically and is intended as temporary or short-term support when a commercial ventilator is unavailable. 

The device builds on the design of standard resuscitator bags used by paramedics and incorporates instruments, sensors and alarms to support automated compressions and patient monitoring. 

More articles on digital transformation: 
NYU develops app that uses biomarkers, AI to generate patient COVID-19 severity scores
Brigham and Women's Hospital, MIT create system that customizes air supply for patients sharing ventilator 
AI, facial recognition & virtual communication: How 4 health systems are using tech to guide return to workplace

© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.

 

Featured Webinars

Featured Whitepapers